Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
2.660
-0.090 (-3.27%)
At close: May 14, 2025, 4:00 PM
2.780
+0.120 (4.51%)
After-hours: May 14, 2025, 7:41 PM EDT
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $79.17 million as of May 14, 2025. Its market cap has decreased by -61.05% in one year.
Market Cap
79.17M
Enterprise Value
76.81M
1-Year Change
-61.05%
Ranking
Category
Stock Price
$2.66
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $79.17M, a decrease of -61.80%. That is a compound annual growth rate of -53.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 81.85M | -33.23% |
| Dec 31, 2024 | 122.58M | -40.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 642.38B |
| Johnson & Johnson | 352.15B |
| AbbVie | 313.43B |
| Novo Nordisk | 288.64B |
| UnitedHealth Group | 279.41B |
| Abbott Laboratories | 223.67B |
| Novartis AG | 208.47B |
| AstraZeneca | 206.71B |